168 related articles for article (PubMed ID: 31394557)
1. Thymic malignancies: emerging systemic therapies.
Girard N
Curr Opin Oncol; 2019 Sep; 31(5):454-460. PubMed ID: 31394557
[TBL] [Abstract][Full Text] [Related]
2. Thymic malignancies: next-generation sequencing as a tool to select patients for targeted therapies and immunotherapies?
Girard N
Mediastinum; 2019; 3():38. PubMed ID: 35118264
[TBL] [Abstract][Full Text] [Related]
3. Novel Agents in the Treatment of Thymic Malignancies.
Merveilleux du Vignaux C; Maury JM; Girard N
Curr Treat Options Oncol; 2017 Aug; 18(9):52. PubMed ID: 28795288
[TBL] [Abstract][Full Text] [Related]
4. Do thymic malignancies respond to target therapies?
Hu B; Rong H; Han Y; Li Q
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):855-9. PubMed ID: 25754373
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies.
Lippner EA; Lewis DB; Robinson WH; Katsumoto TR
Curr Treat Options Oncol; 2019 Jun; 20(7):62. PubMed ID: 31227926
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapeutic options in thymic malignancies: a glimmer of hope.
Hammond-Thelin LA; Thomas CR
Rev Recent Clin Trials; 2007 Sep; 2(3):191-205. PubMed ID: 18474005
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment for thymic malignancies.
Girard N; Merveilleux du Vignaux C
Curr Opin Oncol; 2017 Mar; 29(2):112-117. PubMed ID: 28027106
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and targeted agents for thymic malignancies.
Girard N
Expert Rev Anticancer Ther; 2012 May; 12(5):685-95. PubMed ID: 22594902
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network.
Remon J; Girard N; Mazieres J; Dansin E; Pichon E; Greillier L; Dubos C; Lindsay CR; Besse B
Lung Cancer; 2016 Jul; 97():99-104. PubMed ID: 27237035
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options in thymomas and thymic carcinomas.
Muto Y; Okuma Y
Expert Rev Anticancer Ther; 2022 Apr; 22(4):401-413. PubMed ID: 35266421
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy in advanced thymoma.
Schmitt J; Loehrer PJ
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S357-60. PubMed ID: 20859133
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatment of advanced thymic malignancies.
Kelly RJ
Am Soc Clin Oncol Educ Book; 2014; ():e367-73. PubMed ID: 24857125
[TBL] [Abstract][Full Text] [Related]
13. Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.
Tateo V; Manuzzi L; De Giglio A; Parisi C; Lamberti G; Campana D; Pantaleo MA
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260538
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for advanced thymic tumors.
Rajan A; Giaccone G
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S361-4. PubMed ID: 20859134
[TBL] [Abstract][Full Text] [Related]
15. Thymic malignancies: Moving forward with new systemic treatments.
Remon J; Lindsay CR; Bluthgen MV; Besse B
Cancer Treat Rev; 2016 May; 46():27-34. PubMed ID: 27057658
[TBL] [Abstract][Full Text] [Related]
16. Thymic tumors: relevant molecular data in the clinic.
Girard N
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S291-5. PubMed ID: 20859122
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy.
Kossai M; Duchemann B; Boutros C; Caramella C; Hollebecque A; Angevin E; Gazzah A; Bahleda R; Ileana E; Massard C; Vielh P; Soria JC; Besse B
Lung Cancer; 2015 Sep; 89(3):306-10. PubMed ID: 26160757
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib effective for rare thymus cancer.
Cancer Discov; 2015 Apr; 5(4):340. PubMed ID: 25680712
[TBL] [Abstract][Full Text] [Related]
19. Thymic malignancies: from clinical management to targeted therapies.
Kelly RJ; Petrini I; Rajan A; Wang Y; Giaccone G
J Clin Oncol; 2011 Dec; 29(36):4820-7. PubMed ID: 22105817
[TBL] [Abstract][Full Text] [Related]
20. Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review.
Berardi R; De Lisa M; Pagliaretta S; Onofri A; Morgese F; Savini A; Ballatore Z; Caramanti M; Santoni M; Mazzanti P; Cascinu S
Cancer Treat Rev; 2014 May; 40(4):495-506. PubMed ID: 24355362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
